Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS). [PDF]
Lei J +7 more
europepmc +1 more source
Osimertinib-related myotoxicity: a disproportionality analysis of the FDA adverse event reporting system. [PDF]
Tan Y, Song Q.
europepmc +1 more source
A real-world data analysis of piroxicam in the FDA Adverse Event Reporting System (FAERS) database. [PDF]
Wang Y, Kong Q.
europepmc +1 more source
A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system data. [PDF]
Huang B, Ma Y, Wang W, Gu S, Wang X.
europepmc +1 more source
Prescriptions for Excellence in Health Care Spring 2010 Dowload Full PDF [PDF]
core +1 more source
Hepatotoxicity associated with anti-neoplastic agents: a pharmacovigilance analysis of the Food and Drug Administration Adverse Event Reporting System database. [PDF]
Shi L, Wang Y, Qu Y, Chen R.
europepmc +1 more source
Real-world safety of Symdeko: insights from the food and drug administration adverse event reporting system. [PDF]
Wei S, Zhang L, Liu C, Qi X.
europepmc +1 more source

